Ucb Biopharma Srl

This study aims to learn about the long-term safety and effectiveness of an investigational drug called bimekizumab for adults with active psoriatic arthritis. Over 1,100 participants who completed earlier studies will receive the drug via injection for up to three years. The mai…

This study aims to understand the long-term safety and effectiveness of the drug zilucoplan for adults with generalized myasthenia gravis (gMG), a chronic autoimmune disease that causes muscle weakness. It is an extension study for 200 participants who have already completed a pr…

This study is testing the long-term safety of bimekizumab, a medication for moderate to severe hidradenitis suppurativa (a painful skin condition). It follows 658 participants who previously completed earlier bimekizumab studies to monitor side effects over extended treatment. Th…

This study is testing the long-term safety and effectiveness of an investigational drug called bimekizumab for people with active axial spondyloarthritis, a group of inflammatory diseases that cause back pain and stiffness. It is an extension study for 508 participants who comple…

This study aims to check the long-term safety and side effects of an inhaled alprazolam device (Staccato) for stopping prolonged seizures. It will enroll about 300 people aged 12 and older with epilepsy who have previously used the device in another study. The main goal is to see…

This study aims to see if a drug called bimekizumab works better than another drug, risankizumab, for adults with active psoriatic arthritis. About 684 participants will receive injections of one of these two drugs for 16 weeks. Researchers will measure improvements in joint pain…

This study is testing a medication called certolizumab pegol in children and teenagers aged 6 to 17 who have moderate to severe plaque psoriasis. The main goals are to see how the drug behaves in the body, how safe it is, and how well it works to control the skin condition. Parti…

This study aims to understand the long-term safety of an investigational drug called dapirolizumab pegol for people with systemic lupus erythematosus (lupus). It will follow 760 participants who completed earlier studies of this drug for up to two years to monitor for side effect…

This study aims to check the long-term safety and side effects of repeated treatment cycles with the drug rozanolixizumab in children aged 2 and older who have generalized myasthenia gravis (gMG). It is an extension study for children who completed a previous trial, allowing them…

This study is testing whether a medication called brivaracetam can safely and effectively control absence seizures in children and young adults aged 2 to 25. Absence seizures cause brief lapses in awareness. The trial involves 153 participants and compares different doses of the …

This study is testing an investigational drug called rozanolixizumab to see if it can prevent relapses and control symptoms in adults with MOG antibody-associated disease (MOG-AD), a rare neurological condition. The trial will involve about 104 participants who will receive eithe…

This study is giving children with a rare autoimmune muscle-weakening disease an extra year of an experimental drug to check its long-term safety. It's open to kids aged 2 and up who finished a previous trial and whose doctors think they could benefit from continuing treatment. T…